MannKind Corp
NASDAQ:MNKD

Watchlist Manager
MannKind Corp Logo
MannKind Corp
NASDAQ:MNKD
Watchlist
Price: 7.275 USD 4.53%
Market Cap: 2B USD
Have any thoughts about
MannKind Corp?
Write Note

Intrinsic Value

The intrinsic value of one MNKD stock under the Base Case scenario is 5.867 USD. Compared to the current market price of 7.275 USD, MannKind Corp is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MNKD Intrinsic Value
5.867 USD
Overvaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
MannKind Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MNKD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MNKD?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about MannKind Corp

Provide an overview of the primary business activities
of MannKind Corp.

What unique competitive advantages
does MannKind Corp hold over its rivals?

What risks and challenges
does MannKind Corp face in the near future?

Has there been any significant insider trading activity
in MannKind Corp recently?

Summarize the latest earnings call
of MannKind Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MannKind Corp.

Provide P/S
for MannKind Corp.

Provide P/E
for MannKind Corp.

Provide P/OCF
for MannKind Corp.

Provide P/FCFE
for MannKind Corp.

Provide P/B
for MannKind Corp.

Provide EV/S
for MannKind Corp.

Provide EV/GP
for MannKind Corp.

Provide EV/EBITDA
for MannKind Corp.

Provide EV/EBIT
for MannKind Corp.

Provide EV/OCF
for MannKind Corp.

Provide EV/FCFF
for MannKind Corp.

Provide EV/IC
for MannKind Corp.

Show me price targets
for MannKind Corp made by professional analysts.

What are the Revenue projections
for MannKind Corp?

How accurate were the past Revenue estimates
for MannKind Corp?

What are the Net Income projections
for MannKind Corp?

How accurate were the past Net Income estimates
for MannKind Corp?

What are the EPS projections
for MannKind Corp?

How accurate were the past EPS estimates
for MannKind Corp?

What are the EBIT projections
for MannKind Corp?

How accurate were the past EBIT estimates
for MannKind Corp?

Compare the revenue forecasts
for MannKind Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MannKind Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MannKind Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of MannKind Corp compared to its peers.

Compare the P/E ratios
of MannKind Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing MannKind Corp with its peers.

Analyze the financial leverage
of MannKind Corp compared to its main competitors.

Show all profitability ratios
for MannKind Corp.

Provide ROE
for MannKind Corp.

Provide ROA
for MannKind Corp.

Provide ROIC
for MannKind Corp.

Provide ROCE
for MannKind Corp.

Provide Gross Margin
for MannKind Corp.

Provide Operating Margin
for MannKind Corp.

Provide Net Margin
for MannKind Corp.

Provide FCF Margin
for MannKind Corp.

Show all solvency ratios
for MannKind Corp.

Provide D/E Ratio
for MannKind Corp.

Provide D/A Ratio
for MannKind Corp.

Provide Interest Coverage Ratio
for MannKind Corp.

Provide Altman Z-Score Ratio
for MannKind Corp.

Provide Quick Ratio
for MannKind Corp.

Provide Current Ratio
for MannKind Corp.

Provide Cash Ratio
for MannKind Corp.

What is the historical Revenue growth
over the last 5 years for MannKind Corp?

What is the historical Net Income growth
over the last 5 years for MannKind Corp?

What is the current Free Cash Flow
of MannKind Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for MannKind Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MannKind Corp

Current Assets 327.7m
Cash & Short-Term Investments 251.6m
Receivables 18.2m
Other Current Assets 57.9m
Non-Current Assets 136.5m
Long-Term Investments 16.8m
PP&E 99m
Intangibles 7.2m
Other Non-Current Assets 13.5m
Current Liabilities 72.1m
Accounts Payable 6.4m
Accrued Liabilities 19.8m
Other Current Liabilities 45.9m
Non-Current Liabilities 602m
Long-Term Debt 459.3m
Other Non-Current Liabilities 142.8m
Efficiency

Earnings Waterfall
MannKind Corp

Revenue
267.2m USD
Cost of Revenue
-75.1m USD
Gross Profit
192.1m USD
Operating Expenses
-134.9m USD
Operating Income
57.3m USD
Other Expenses
-35.7m USD
Net Income
21.6m USD

Free Cash Flow Analysis
MannKind Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MNKD Profitability Score
Profitability Due Diligence

MannKind Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive 3-Year Average ROE
ROIC is Increasing
45/100
Profitability
Score

MannKind Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

MNKD Solvency Score
Solvency Due Diligence

MannKind Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Positive Net Debt
Long-Term Solvency
42/100
Solvency
Score

MannKind Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MNKD Price Targets Summary
MannKind Corp

Wall Street analysts forecast MNKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MNKD is 7.956 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
31% Downside
Average
Price Target
7.956 USD
9% Upside
Highest
Price Target
12.6 USD
73% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MNKD?

Click here to dive deeper.

Dividends

MannKind Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for MNKD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MNKD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

MannKind Corp Logo
MannKind Corp

Country

United States of America

Industry

Biotechnology

Market Cap

1.9B USD

Dividend Yield

0%

Description

MannKind Corp. operates as a biopharmaceutical company. The company is headquartered in Danbury, Connecticut and currently employs 348 full-time employees. The company went IPO on 2004-07-28. The firm is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. AFREZZA utilizes its Technosphere formulation technology. The Technosphere is a drug delivery platform that allow the oral inhalation of a range of therapeutics.

Contact

CONNECTICUT
Danbury
1 Casper Street
+18186615000.0
www.mannkindcorp.com

IPO

2004-07-28

Employees

348

Officers

CEO & Director
Dr. Michael E. Castagna Pharm.D.
Chief Operating Officer
Ms. Lauren M. Sabella
Executive VP, General Counsel & Secretary
Dr. David B. Thomson J.D., Ph.D.
Executive VP and Chief People & Workplace Officer
Dr. Stuart A. Tross Ph.D.
Chief Financial Officer
Mr. Christopher B. Prentiss M.B.A.
Executive Vice President of Technical Operations
Mr. Sanjay Singh M.B.A.
Show More
VP of Investor Relations & Treasury
Ms. Rosabel Realica Alinaya
Senior Vice President of Worldwide Regulatory Affairs
Mr. John F. Bedard
Chief Commercial Officer
Mr. James Patrick McCauley Jr., J.D., M.B.A.
Executive VP of Research & Development and Chief Medical Officer
Dr. Burkhard Blank M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one MNKD stock?

The intrinsic value of one MNKD stock under the Base Case scenario is 5.867 USD.

Is MNKD stock undervalued or overvalued?

Compared to the current market price of 7.275 USD, MannKind Corp is Overvalued by 19%.

Back to Top